iHIVARNA-01

N/A

Report date: 2026/05/12 09:09:09

Base Information

Drug NameiHIVARNA-01

Drug Alias NameiHIVARNA-01

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine

Mechanisms of ActionAnti-CD70Toll like receptor 4 modulatorsCD40 ligand modulators

TargetsCD40 ligandToll like receptor 4CD70 antigen

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumNetherlandsSpain

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesIdibaps - Institut D'Investigacions Biomèdiques August Pi I Sunyer Hospital Clinic Of Barcelona (Es)

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHospital Clinic Of Barcelona (Es)

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A